Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kiyoshi Nara is active.

Publication


Featured researches published by Kiyoshi Nara.


Archive | 1994

Food Applications of Curdlan

Masanori Miwa; Yukihiro Nakao; Kiyoshi Nara

Curdlan is a polysaccharide produced by bacteria and a homopolymer of glucose with β-1,3-glucosidic linkage. Its unique characteristic is its ability to form a firm, resilient and thermo-irreversible gel when heated in an aqueous suspension higher than 800C. Also, the curdlan gel does not melt even when it is heated to above 1000C, for example, during processes such as thermal sterilization. Moreover, curdlan gel, which is different from the gels made from other gelling agents, such as carrageenan, agar-agar and konjac, is stable against freezing and thawing.


Journal of Biotechnology | 1987

Purification of human leukocyte interferon A derived from Escherichia coli: An aging process to prevent the formation of its oligomers

Susumu Honda; Hiromu Sugino; Kiyoshi Nishi; Kiyoshi Nara; Atsushi Kakinuma

Abstract Recombinant human leukocyte interferon A (rIFN-αA) was purified from Escherichia coli cells by monoclonal antibody affinity chromatography (Ab) and CM-cellulose column chromatography (CM). By sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the CM eluate was found to contain a large amount of rIFN-αA oligomers, in addition to the monomer, linked by intermolecular disulfide bonds. In contrast, the Ab eluate was found to contain a large amount of rIFN-αA monomers. These results show that the oligomers were formed at the CM step. Free SH groups were detected at a significant level in the Ab eluate, but were detected barely in the CM eluate, indicating that the Ab eluate contained some amount of the unstable monomer with free SH groups. To prevent the formation of the oligomers we established a simple and easily scaled-up process, called an aging process, during which the Ab eluate was incubated at pH 3.3 at 37°C for several days. This process is effective for changing the unstable monomer to the stable monomer and thus preventing the formation of the oligomers.


Nature | 1973

New findings on cephalosporin C biosynthesis.

Yukio Fujisawa; Hideo Shirafuji; Makoto Kida; Kiyoshi Nara; Masahiko Yoneda; Toshihiko Kanzaki


Journal of interferon research | 1987

Differential Purification by Immunoaffinity Chromatography of Two Carboxy-Terminal Portion-Deleted Derivatives of Recombinant Human Interferon-γ from Escherichia coli

Susumu Honda; Tsuneo Asano; Tomoko Kajio; Shizue Nakagawa; Shuichi Ikeyama; Yuzo Ichimori; Hiromu Sugino; Kiyoshi Nara; Atsushi Kakinuma; Hsiang-Fu Kung


Chemical & Pharmaceutical Bulletin | 1995

Phosphorylation of Nucleosides with Phosphorus Oxychloride in Trialkyl Phosphate

Tomomi Ikemoto; Akira Haze; Hiroyuki Hatano; Yoshifumi Kitamoto; Masato Ishida; Kiyoshi Nara


Agricultural and biological chemistry | 1975

Accumulation of deacetylcephalosporin C by cephalosporin C negative mutants of Cephalosporium acremonium.

Yukio Fujisawa; Hideo Shirafuji; Makoto Kida; Kiyoshi Nara; Masahiko Yoneda; Toshihiko Kanzaki


Agricultural and biological chemistry | 1974

Production of cephalosporin antibiotics by strains belonging to the genera Arachnomyces, Anixiopsis and Spiroidium.

Kazuaki Kitano; Kazuhiko Kintaka; Shigeru Suzuki; Kazuyoshi Katamoto; Kiyoshi Nara; Yoshio Nakao


Journal of Biochemistry | 1975

The Aconitase of Yeast II. Crystallization and General Properties of Yeast Aconitase

Takashi Suzuki; Osamu Yamazaki; Kiyoshi Nara; Shun-ichi Akiyama; Yoshio Nakao; Hideo Fukuda


Archive | 1976

Method for preparing antibiotic P-2563 using Pseudomonas fluorescens

Kiyoshi Nara; Yasuhiro Sumino; Mitsuko Asai; Shun-ichi Akiyama


Archive | 1985

Highly solubilized protein and production thereof

Kiyoshi Nara; Susumi Honda

Collaboration


Dive into the Kiyoshi Nara's collaboration.

Top Co-Authors

Avatar

Kazuyoshi Katamoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hideo Fukuda

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kazuhiko Ohta

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Shun-ichi Akiyama

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Susumu Honda

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yoshio Nakao

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Akira Haze

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Shigeru Suzuki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Toshihiko Kanzaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kazuaki Kitano

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge